What’s The Risk? New article about tCSM by DZS to appear in International Clinical Trials journal

What’s The Risk?” – New article about tCSM by DZS to appear in International Clinical Trials journal Recently, Greg Ambra and Jean Battikha collaborated on an article that will be featured in this month’s International Clinical Trials titled, “What’s The Risk?”.  The article features a novel scientific approach to identifying clinical trial data risk for […]

DZS Supported Clinical Study of 5-ALA SFC in Middle East

DZS supported clinical study in Middle East recently published in the Journal of Diabetes Research DZS supported one of the first pharmaceutical sponsored clinical research studies entirely performed in the Kingdom of Bahrain. The study of 5-ALA SFC, sponsored by SBI Pharmaceuticals, was recently published in a local journal. This pilot trial studied the safety […]

Technology in Clinical Trials, What We’re Talking About This Week

  1.  The Clinical Trial of the Future Technology in clinical trials is allowing for a new age of trials that are streamlined, connected and more engaged with the patient; but only if pharma can embrace the changes. 2. Is Industry Consolidation Stifling Pharma Innovation? In a year of “merger mania,” researchers suggest the elimination of competition […]